A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy
Clinical trial NCT07235085 · RECRUITING
Trial details
- NCT number
- NCT07235085
- Sponsor
- Ocular Therapeutix, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-17
- Primary completion
- 2027-03-01
- Enrollment
- 930
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.